When was KBI Biopharma founded?

KBI Biopharma was founded in 1996 and raised its 1st funding round 7 years after it was founded.

Where is KBI Biopharma located?

KBI Biopharma is headquartered in Durham, United States. It is registered at Durham, North Carolina.

How many employees does KBI Biopharma have?

As of Aug 31, 2026, the latest employee count at KBI Biopharma is 1680.

Is KBI Biopharma a funded company?

KBI Biopharma is a funded company, having raised a total of $21M across 5 funding rounds to date. The company's 1st funding round was a $***** Venture Debt round, raised on Apr 2003.

When was the latest funding round of KBI Biopharma?

KBI Biopharma's latest funding was a $***** Series A round on Aug 14, 2009, with participation from 0 investor.

Where does KBI Biopharma rank among its competitors?

KBI Biopharma ranks 4th amongst 340 active competitors, of which 22 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was Abingdon Health, which secured $4.4M in Oct, 2025.

Who are the top competitors of KBI Biopharma?

KBI Biopharma's top competitors include Anthem Biosciences, Patheon and Aragen. Among them, Abingdon Health secured the most recent funding round in October, 2025.

KBI Biopharma - 2026 Company Profile, Funding & Competitors

KBI Biopharma is an acquired company based in Durham (United States), founded in 1996. It operates as a Provider of protein formulation, process & cell line development, and cGMP services. KBI Biopharma has raised $21M in funding. The company has 340 active competitors, including 22 funded and 98 that have exited. Its top competitors include companies like Anthem Biosciences, Patheon and Aragen.

Company Details

Website: www.kbibiopharma.com/
Social
Part Of
Registered Address: Durham, North Carolina

Key Metrics

Founded Year

1996

Location

Durham, United States

Stage

Acquired

Total Funding

$21M in 5 rounds

Latest Funding Round

Series A, Aug 14, 2009, $*****

Investors

Ballast Point Ventures & 2 more

Ranked

4^th among 340 active competitors

Employee Count

1,680 as on Aug 31, 2026

Investment & Acquisitions

Iqtech & 5 more

Similar Companies

EirGenix & 159 more

Exit Details

Acquired by JSR Life Sciences (Feb 26, 2015)

View KBI Biopharma's full profile

KBI Biopharma is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
KBI CIN: 40003974974 , Latvia, Active	Dec 04, 2007	€0 - €1M (As on Dec 31, 2024)	2 (As on Dec 31, 2023)	-
KBI BIOPHARMA, INC. CIN: 800058312 , United States, Active	Dec 26, 999	-	1398 (As on Dec 31, 2024)	-

KBI Biopharma got acquired by JSR Life Sciences, CMiC and INCJ on Feb 26, 2015.

Click here to take a look at KBI Biopharma's acquisition in detail

KBI Biopharma has raised a total funding of $21M over 5 rounds. Its first funding round was on Apr 2003. KBI Biopharma has 3 institutional investors.

Here is the list of recent funding rounds of KBI Biopharma:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 14, 2009	5591459	Series A	5468670	7626482	7276469	5004657
Feb 2009	4273176	Series A	4496411	6715859	1974364	Ballast Point Ventures
Sep 2008	9279786	Unattributed	4056976	3102732	5119899	9162178

Access funding benchmarks and valuations. Sign up today!

View details of KBI Biopharma's funding rounds and investors

KBI Biopharma's employee count trend

KBI Biopharma has 1,680 employees as of Aug 26. Here is KBI Biopharma's employee count trend over the years:

Uncover KBI Biopharma's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of KBI Biopharma include Anthem Biosciences, Patheon and Aragen. Here is the list of Top 10 competitors of KBI Biopharma, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Anthem Biosciences 2006, Bengaluru (India), Public	Developer of integrated contract research development and manufacturing services	$35.7M	Portsmouthtechnologiestrialsunit, True North ... & 8 others	76/100
2nd	Patheon 1974, Durham (United States), Acquired	Global CDMO providing integrated drug development, clinical trials, and manufacturing services	$141M	Frazier Healthcare Partners, Audax Group & 3 others	74/100
3rd	Aragen 2001, Hyderabad (India), Series B	Provider of drug discovery, clinical development, manufacturing, and other services for small molecules	$161M	Goldman Sachs, Quadria Capital & 18 others	69/100
4th	KBI Biopharma 1996, Durham (United States), Acquired	Provider of protein formulation, process & cell line development, and cGMP services	$21M	Ballast Point Ventures, NCBiotech & 1 others	69/100
5th	Syngene 1993, Bengaluru (India), Public	Provider of contract research and manufacturing services for both small molecules and biologics	$85.9M	True North, Education Growth Partners & 9 others	66/100
6th	Abzena 2001, Cambridge (United Kingdom), Acquired	Provider of antibody discovery, cell line development, and bio analytics services	$67.1M	Imperial Innovations, Invesco Perpetual & 11 others	66/100
7th	Abingdon Health 2008, York (United Kingdom), Public	Developer of immunoassays for diagnostic purposes	$24.1M	Imperial Innovations, Mercia & 2 others	64/100
8th	Panacea Biotec 1984, Ambala (India), Public	Developer of biosimilars, vaccines and natural products	-	India Resurgence Fund, Department of Biotechnology ... & 1 others	62/100
9th	Grand River Aseptic Manufacturing 2010, Grand Rapids (United States), Acquired	Aseptic manufacturing CDMO providing fill-finish services for sterile injectables	$16.9M	Municipal Employees' Retirement System, Trout Creek Ventures ... & 5 others	59/100
10th	EirGenix 2012, Taipei (Taiwan), Public	Contract development and manufacturing organization for biologics	-	CDIB Capital Group, Taiwania Capital & 3 others	58/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on KBI Biopharma's competitors? Click here to see the top ones

KBI Biopharma has made 5 investments in companies including Iqtech and AbSci. KBI Biopharma has also acquired 1 companies including Alliance Protein Laboratories.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Mar 05, 2026	Investments	Iqtech	2005	Bloemfontein (South Africa)
Dec 18, 2019	Investments	AbSci	2011	Vancouver (United States)
Oct 24, 2017	Investments	GlycoSeLect	2013	Dublin (Ireland)